Calyculin A-induced decrease of tyrosine-monophosphorylated ERK2 at high cell density. by Noriyuki Kawabata (3391739)

Penicillin non-susceptibility¹ of S. pneumoniae over time, by country and sample size [11, 12, 60, 66, 68–73, 75–77, 79–86]. by Heloisa Ricci Conesa (18291210)

Subjects:

<i>son</i> reduction decreases T cell numbers. by Rebecca L. Belmonte (8384103)

SOD1 deficiency and the HM/LF diet produce an additive increase in endothelial dysfunction and induce a non-additive decrease in vasodilator responses to nitroprusside and papaveri... by Sanjana Dayal (630357)

APC decreases epithelial cytotoxicity induced by histones but not by NET. by Mona Saffarzadeh (180792)

Nur77 knockdown decreases cell viability and proliferation. by Alexa Tenga (2161780)

“…<p>(A) Daoy cells were transfected with 20 nM siNur77 or non-targeting control (NT), and cell viability was measured via the CellTiter-Glo assay every day for 3 days. …”

S5 Fig - by Meghan J. Hirsch (16528311)

“…Our model shows with an inoculum of 2 x 10² CFUs of PA for 24 hours pro-inflammatory markers such as interleukin 6 and interleukin 8 are upregulated with little decrease in CF bronchial epithelial cell survival or monolayer confluency. …”

Decreased HIF levels associated with hyperoxic cell state. by Julie M. Koeman (108185)

“…<p>(A) Normalized densitometry of HIF-1α protein levels (•),HIF-1β protein levels (▴), and HIF-1 DNA-binding activity (⧫) as presented in <a href="http://www.plosgenetics.org/article/info:doi/10.1371/journal.pgen.1000176#pgen-1000176-g005" target="_blank">Figure 5B</a> of the Jiang et al. article. …”

Human preterm infants diagnosed with IUGR have decreased Paneth cell counts compared to preterm non-IUGR control infants. by Camille M. Fung (844334)

“…Infants with a diagnosis of IUGR (n = 9) were compared to age-matched non-IUGR infants (n = 4). (A) IUGR infants had similar numbers of goblet cells per 100 epithelial cells compared to non-IUGR infants (p = 0.5). …”

Vectorized siRNA TMPRSS2-ERG IV-SQ impaired tumour growth and restored differentiation <i>in vivo</i>. by Giorgia Urbinati (554921)

“…<p><b>a.</b> SCID mice (n = 5/group) bearing VCaP tumour xenografts were injected intravenously either with NaCl 0.9%, non-vectorized siRNA TMPRSS2-ERG IV, NPs siRNA control-SQ or NPs siRNA TMPRSS2-ERG IV-SQ twice per week during 6 weeks (1.8 mg/kg/mouse cumulative dose). …”

S1 File - Assessment and analysis of agricultural non-point source pollution loads in Henan, China: 2001–2023 by Cangyu Li (10312677)

DualAG decreased TG synthesis in DIO mice. by Vijay R. More (4532392)

Table 1_Previous treatment decreases efficacy of pralsetinib in RET fusion-positive non-small-cell lung cancer.doc by Lei Wang (6656)

“…The ARROW trial revealed that RET fusion-positive non-small-cell lung cancer (NSCLC) can benefit from pralsetinib with tolerable adverse events (AEs). …”

Deterioration of the anammox process at decreasing temperatures and long SRTs by Maaike Hoekstra (3915545)

The negative ecological impacts of a globally introduced species decrease with time since introduction by Libor Zavorka (828469)

Yta4 decreases the affinity of Dnm1 for GTP. by Jiajia He (795335)

Growth on stiff substrate results in mild lifespan extension but a decrease in organismal health. by Maria Oorloff (19658113)

Silencing of dynamin II decreases apoE secretion. by Maaike Kockx (154125)

Fold change of TIL subsets in paired TNBCs (N = 12 pts including 10 prim-met, and 2 met-met specimens) using log2 ratio of metastatic versus primary TNBC (n = 10, ●) or second recu... by Ting-Fang He (5210948)

Low concentrations of siRNA TMPRSS2-ERG III and IV impair TMPRSS2-ERG oncogene and oncoprotein levels but not cell viability. by Giorgia Urbinati (554921)

“…<p>VCaP cells were transfected for 72h from 2.5 nM to 50 nM with siRNA TMPRSS2-ERG III, siRNA TMPRSS2-ERG IV or siRNA Control. …”